ARTICLE | Clinical News
Vonapanitase: Ph I started
November 11, 2016 8:29 PM UTC
Proteon began a double-blind, placebo-controlled, dose-escalation, U.S. Phase I trial to evaluate a single perivascular injection of vonapanitase delivered via micro-infusion catheter in up to 40 pati...
BCIQ Company Profiles